Form 4: Elevance Health Executive Ratnakar Lavu Reports Stock and Option Awards
SEC Form 4 Filing
Ratnakar Lavu, EVP & Chief Digital Officer of Elevance Health, reports the acquisition of stock and option awards.
Summary
- Ratnakar Lavu, an executive at Elevance Health, filed a Form 4 detailing changes in beneficial ownership.
- On March 1, 2024, Lavu acquired 1,754 restricted share units and an additional 1,002 restricted share units, both at a price of $0.
- These restricted share units vest over three and two years respectively.
- Lavu also acquired options to purchase 6,765 shares of common stock at an exercise price of $499.11, vesting in three annual installments starting March 1, 2025.
- Following these transactions, Lavu directly owns 2,756 shares of common stock and options to purchase 6,765 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of executive compensation. The stock and option awards suggest a positive outlook for the company, but it's not overtly bullish.
Positives
- The acquisition of restricted share units and stock options suggests confidence in Elevance Health's future performance.
Future Outlook
The vesting schedules for the restricted share units and stock options indicate a multi-year incentive plan for the executive.
Industry Context
Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in company stock.
Stakeholder Impact
- The stock and option awards align the executive's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transaction: acquisition of restricted share units and stock options. |
| 03/01/2025 | First vesting date for 584 restricted share units and 501 restricted share units. |
| 03/01/2025 | First exercisable date for 2,255 stock options. |
| 03/01/2026 | Second vesting date for 585 restricted share units and 501 restricted share units. |
| 03/01/2026 | Second exercisable date for 2,255 stock options. |
| 03/01/2027 | Final vesting date for 585 restricted share units. |
| 03/01/2027 | Final exercisable date for 2,255 stock options. |
| 03/01/2034 | Expiration date for the stock options. |
| 03/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.